CONFERENCE COVERAGE
European Association for the Study of Diabetes
Annual Meeting
2019 COVERAGE
- Vitamin D Deficiency Linked to Increased Mortality
- Dapagliflozin May Lower Risk for Worsening Heart Failure
- Comparison of Linagliptin With Glimepiride for CV Safety in T2D
- Lower CV Risk With Metformin vs Sulfonylureas in T2D With Reduced Kidney Function
- Liraglutide Improves Glycemic Control in Children and Adolescents With T2D
- Cardiorenal Disease Is the Most Common CVD Manifestation in Patients With T2D
- Imeglimin, a First-in-Class Oral Antidiabetes Medication, May Be Effective in T2D
- ADO09 Confers Better Glucose Control Than Insulin Lispro in T1D
- PEX168, a Novel GLP-1ra, Has Favorable Efficacy and Safety Profile in T2D
- Fatty Liver Index Identifies Individuals at Risk of Developing Type 2 Diabetes
- Canagliflozin May Reduce Gout-Related Adverse Events, Uric Acid Levels in T2D
Latest Tweets
Follow
@EndoAdvisor
Conference Coverage from
